Literature DB >> 7174788

In vivo clearance and tissue distribution of C5a and C5a des arginine complement fragments in rabbits.

R O Webster, G L Larsen, P M Henson.   

Abstract

We have previously shown a marked difference in the inflammatory response to human C5a or C5a des arginine (Arg) instilled in rabbit lungs. These studies raised the question of where C5a and C5a des Arg are processes in vivo and what role neutrophils may play in the tissue distribution of these two mediators. After intravenous injection of purified, biologically active 125I-C5a or 125I-C5a des Arg, adult rabbits were serially bled and then killed at various time intervals. Although greater than 50% of the injected radioactivity was cleared from the circulation within 2 min for both mediators, C5a des Arg persisted in the circulation longer than C5a. C5a instillation caused an acute neutropenia, whereas C5a des Arg caused a less severe and more prolonged neutropenia, preceding a neutrophilic response observed with both mediators. Clearance of the mediators was primarily seen in the highly vascularized organs: the lung, spleen, liver, and kidney. A time-dependent accumulation was seen initially in the lung, followed by the spleen, liver, and kidney. Histologic examination showed a marked increase in the number of neutrophils within the lung and spleen. Depletion of circulating neutrophils by nitrogen mustard pretreatment of rabbits showed no change in the amount of labeled mediator bound in the lung, whereas splenic accumulation was dependent on the presence of neutrophils. These results indicate that C5a and C5a des Arg are rapidly removed from the circulation by specific accumulation in vascularized tissues. Clearance by the lung was not affected by neutrophil depletion, whereas clearance by the spleen was dependent on neutrophils. These experiments further suggest there are neutrophil-dependent and neutrophil-independent mechanisms involved in the removal of C5a and C5a des Arg from the circulation and that binding of C5 fragments in the pulmonary vasculature may precede and then induce neutrophil sequestration.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7174788      PMCID: PMC370334          DOI: 10.1172/jci110716

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

2.  Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization.

Authors:  C Gerard; T E Hugli
Journal:  J Biol Chem       Date:  1979-07-25       Impact factor: 5.157

3.  Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.

Authors:  C G Cochrane; H J Müller-Eberhard; B S Aikin
Journal:  J Immunol       Date:  1970-07       Impact factor: 5.422

4.  Clearance of thrombin from circulation in rabbits by high-affinity binding sites on endothelium. Possible role in the inactivation of thrombin by antithrombin III.

Authors:  P Lollar; W G Owen
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

5.  Response of human neutrophils to C5a: a role for the oligosaccharide moiety of human C5ades Arg-74 but not of C5a in biologic activity.

Authors:  C Gerard; D E Chenoweth; T E Hugli
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

6.  Phospholipase A2 contamination of cobra venom factor preparations. Biologic role in complement-dependent in vivo reactions and inactivation with p-bromophenacyl bromide.

Authors:  J O Shaw; M F Roberts; R J Ulevitch; P Henson; E A Dennis
Journal:  Am J Pathol       Date:  1978-06       Impact factor: 4.307

7.  Absence of inflammatory lung injury in rabbits challenged intravascularly with complement-derived chemotactic factors.

Authors:  R O Webster; G L Larsen; B C Mitchell; A J Goins; P M Henson
Journal:  Am Rev Respir Dis       Date:  1982-03

8.  Distribution of endotoxin (lipopolysaccharide) in the tissues of lipopolysaccharide-responsive and -unresponsive mice.

Authors:  R A Musson; D C Morrison; R J Ulevitch
Journal:  Infect Immun       Date:  1978-08       Impact factor: 3.441

9.  Production of acute pulmonary injury by leukocytes and activated complement.

Authors:  D C Hohn; A J Meyers; S T Gherini; A Beckmann; R E Markison; A M Churg
Journal:  Surgery       Date:  1980-07       Impact factor: 3.982

10.  Adhesion of leukocytes to endothelium: roles of divalent cations, surface charge, chemotactic agents and substrate.

Authors:  R L Hoover; R Folger; W A Haering; B R Ware; M J Karnovsky
Journal:  J Cell Sci       Date:  1980-10       Impact factor: 5.285

View more
  21 in total

1.  Extracellular histones are essential effectors of C5aR- and C5L2-mediated tissue damage and inflammation in acute lung injury.

Authors:  Markus Bosmann; Jamison J Grailer; Robert Ruemmler; Norman F Russkamp; Firas S Zetoune; J Vidya Sarma; Theodore J Standiford; Peter A Ward
Journal:  FASEB J       Date:  2013-08-27       Impact factor: 5.191

2.  Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation.

Authors:  S E Lind; D B Smith; P A Janmey; T P Stossel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

3.  Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.

Authors:  Norman F Russkamp; Robert Ruemmler; Julian Roewe; Bethany B Moore; Peter A Ward; Markus Bosmann
Journal:  FASEB J       Date:  2015-05-21       Impact factor: 5.191

4.  Characterization of murine monoclonal antibodies that recognize neutralizing epitopes on human C5a.

Authors:  J W Larrick; J Wang; B M Fendly; D E Chenoweth; S L Kunkel; T Deinhart
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

5.  Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.

Authors:  Griet A Van Roey; Christopher C Vanison; Jeffanie Wu; Julia H Huang; Lydia A Suh; Roderick G Carter; James E Norton; Stephanie Shintani-Smith; David B Conley; Kevin C Welch; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Whitney W Stevens; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2016-12-12       Impact factor: 10.793

6.  Complement activation is involved in biological responses to leukocyte adsorptive apheresis.

Authors:  Shoichi Nishise; Yuji Takeda; Hiroaki Takeda; Katsuyoshi Ishihama; Tadahisa Fukui; Sumio Kawata
Journal:  Dig Dis Sci       Date:  2006-04-27       Impact factor: 3.199

7.  Studies of human C5a as a mediator of inflammation in normal human skin.

Authors:  K B Yancey; C H Hammer; L Harvath; L Renfer; M M Frank; T J Lawley
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  MyD88-dependent production of IL-17F is modulated by the anaphylatoxin C5a via the Akt signaling pathway.

Authors:  Markus Bosmann; Vinay R Patel; Norman F Russkamp; Florence Pache; Firas S Zetoune; J Vidya Sarma; Peter A Ward
Journal:  FASEB J       Date:  2011-08-22       Impact factor: 5.191

9.  Complement activation on neutrophils initiates endothelial adhesion and extravasation.

Authors:  Antonina Akk; Luke E Springer; Lihua Yang; Samantha Hamilton-Burdess; John D Lambris; Huimin Yan; Ying Hu; Xiaobo Wu; Dennis E Hourcade; Mark J Miller; Christine T N Pham
Journal:  Mol Immunol       Date:  2019-09-19       Impact factor: 4.407

10.  Generation of chemotactic activity in serum by Haemophilus influenzae type b.

Authors:  M F Tosi; S L Kaplan; E O Mason; G J Buffone; D C Anderson
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.